|
HS Code |
111730 |
| Chemical Name | 1-(4-Fluorophenyl)Imidazole |
| Cas Number | 2525-24-8 |
| Molecular Formula | C9H7FN2 |
| Molecular Weight | 162.17 g/mol |
| Appearance | White to off-white crystalline powder |
| Melting Point | 53-55°C |
| Boiling Point | 310-312°C |
| Density | 1.19 g/cm³ |
| Solubility | Soluble in organic solvents such as DMSO and methanol |
| Smiles | c1ccc(cc1n2ccnc2)F |
| Inchi | InChI=1S/C9H7FN2/c10-8-3-1-7(2-4-8)12-6-5-11-9-12/h1-6H |
| Synonyms | 4-Fluorophenylimidazole |
| Purity | Typically ≥98% |
| Refractive Index | 1.624 |
As an accredited 1-(4-Fluorophenyl)Imidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 25 grams of 1-(4-Fluorophenyl)imidazole, sealed with a screw cap and labeled with safety information. |
| Shipping | 1-(4-Fluorophenyl)Imidazole is shipped in tightly sealed containers to prevent moisture and contamination. It is packaged according to hazardous material regulations, with clear labeling and proper documentation. During transport, it is kept away from incompatible substances, direct sunlight, and extreme temperatures to ensure safe delivery and maintain product stability and integrity. |
| Storage | **1-(4-Fluorophenyl)imidazole** should be stored in a tightly closed container in a cool, dry, and well-ventilated area, away from incompatible substances such as strong oxidizers. Protect the chemical from moisture and light. Store at room temperature or as recommended by the manufacturer. Always use proper chemical storage protocols and label containers clearly for safe handling. |
Applications of 1-(4-Fluorophenyl)Imidazole in Industrial ManufacturingAs an established manufacturer, we supply 1-(4-Fluorophenyl)Imidazole to clients operating in tightly regulated sectors that demand high-purity intermediates for synthesis and formulation. The following application scenarios outline precise industrial roles where this molecule contributes technical and economic value, alongside industry-specific requirements for compliance, formulation, and product integration. 1. Pharmaceutical API Synthesis: Azole Antifungal Agents1-(4-Fluorophenyl)Imidazole functions as an advanced building block in the synthesis of azole class antifungal active pharmaceutical ingredients (APIs), where halogenated imidazoles enable targeted inhibitory activity against pathogenic fungi. Multistep pharmaceutical synthesis processes utilize this raw material in key N-alkylation or N-arylation transformations to construct imidazole antifungals that comply with global regulatory benchmarks. Process chemists define usage levels by molar requirements and impurity profiles, strictly regulated under cGMP environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate Manufacturing: Fungicide SynthesisDownstream agrochemical producers employ this molecule as a key precursor during manufacturing of triazole and imidazole fungicides. Its reactivity profile supports selective modification for enhanced crop protection, conforming to food and environmental safety regulations. Process operators manage strict input controls for residue minimization and batch traceability, adjusting input ratios according to product strength and formulation design. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pharmaceutical Intermediate for CNS Drug DevelopmentR&D-based drug manufacturers use this compound as a functional intermediate in the creation of 4-fluorophenyl imidazole-based modulators for central nervous system (CNS) targets. Medicinal chemistry labs require strict supply chain and batch certification, since this stage determines pharmacological specificity and metabolic properties. Custom synthesis groups modulate additive proportions to optimize synthetic output and purity for subsequent clinical trial APIs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Chemical Synthesis for Advanced Polymer AdditivesProducers of specialty polymers and advanced resin systems utilize this imidazole derivative as a functionalizing monomer or hardener precursor, specifically for applications requiring enhanced resistance to hydrolysis and chemical degradation. Quality assurance teams routinely verify integration efficacy and compliance with end-use safety guidelines. Formulations adjust loading ratios per desired cross-link density and performance testing results. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Electronic Chemicals: Semiconductor Photoresist IntermediateFabricators in the electronics sector select this compound for next-generation photoresist systems deployed in advanced lithography and semiconductor patterning processes. Strict adherence to semiconductor purity grades and trace metal content limits defines procurement and batch release. Formulators fine-tune mass fraction to enhance resist sensitivity and pattern fidelity, responding to shrinking device geometries as specified by industry technology roadmaps. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-(4-Fluorophenyl)Imidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working on the production floor and within R&D labs, our team has handled countless heterocyclic compounds, but there’s a sense of satisfaction when batches of 1-(4-Fluorophenyl)Imidazole meet rigorous purity needs. We produce this material predominantly for research and process applications because its molecular framework – combining a fluorinated phenyl ring with imidazole – brings a valuable property balance. Our chemists pursue batch consistency by verifying every lot through HPLC and NMR, making sure each kilogram offers reliable quality whether used by a major pharmaceutical research group or a material science lab.
The fluoro group at the para position on the phenyl ring plays a distinct role in the molecule’s behavior. We’ve observed that this substitution often fine-tunes the electron distribution in the imidazole system, which in turn shapes both its chemical reactivity and its compatibility with a wide range of synthetic targets. This property makes the compound attractive for engineers exploring new routes for kinase inhibitors, antifungal agents, and ligand development.
Our process focuses on a technically pure grade of 1-(4-Fluorophenyl)Imidazole, with a molecular formula C9H7FN2. Target purity ranges above 98 percent by HPLC are set, since many research workflows require minimal by-product content. Moisture level is always checked before packing; low water content preserves reactivity for sensitive condensation or coupling reactions. Melting point runs between 90-95°C, which matches literature values and helps to provide a quick confirmation of product integrity. Appearance is a white to off-white crystalline solid, though slight shade changes can occur as a function of process temperature, never affecting key analytical values.
Packaging is typically designed to reduce environmental exposure and preserve batch stability during worldwide transport. Standard pack sizes start at 100 grams and scale up to multi-kilogram drums for bulk users. We seal each container with a tamper-evident barrier, a decision informed after seeing how easily open-top containers allowed even trace moisture changes that compromised product dryness in early years.
Researchers choose 1-(4-Fluorophenyl)Imidazole for projects that need precision. In practice, modern medicinal chemists often rely on its aromatic core to explore new drug analogs. The unique ring system, once introduced into target molecules, sometimes improves both binding affinity and metabolic stability in enzyme assays. Our customers in pharmaceutical discovery sometimes report success stories where this building block streamlines the lead optimization process, thanks to both its chemical resilience and the subtle influence of the fluoro group on molecular interactions.
Academic projects aimed at synthesizing metal-ligand complexes or catalytic systems also benefit from this compound. Imidazoles have a proven history of functioning as effective chelators and intermolecular connectors. We’ve seen 1-(4-Fluorophenyl)Imidazole used in ligand synthesis where the electron-withdrawing effect offered by the para-fluorine atom unlocks different reactivity compared with unsubstituted or ortho/meta variants. This detail has led to several new application pathways, especially when developing catalysts that require fine-tuned back-donation properties or substrate selectivity.
Each aromatic imidazole brings something different to the bench or the pilot reactor. In conversations with formulation chemists and library designers, practical distinctions between similar building blocks often come to light only after hands-on application. 1-Phenylimidazole, for example, lacks the electron-withdrawing fluorine, leading to higher electron density in the ring and changing reactivity toward alkylation or further functionalization. The para-fluorinated derivative, in contrast, shifts electron balance and makes certain coupling or substitution reactions more predictable and controlled, particularly on multi-step synthetic routes.
We’ve also seen differences in downstream handling. The fluoro-substituted imidazole has shown greater thermal stability compared to its non-fluorinated counterpart under similar process conditions. This advantage matters when scaling from analytical work to pilot production – any small gain in stability can translate to fewer side-products during heat-activated steps.
From a safety management point of view, the compound behaves similarly to other small-molecule imidazoles. It requires standard ventilation, dust control, and personal protective gear, but it does not exhibit the acute toxicity associated with many halogenated aromatics. Fluorine’s presence does not lead to the same volatility or corrosiveness seen with some higher fluorinated analogs, but routine best practices for organic solids always apply. Several of our process operators comment on the ease of weighing and blending this product due to its crystalline habit, which reduces airborne dispersal risk compared to finer, more hygroscopic materials.
Our experience with end-users across three continents shows that researchers often choose 1-(4-Fluorophenyl)Imidazole strictly for the synthetic control it affords in structure-activity relationship studies. Its tailored electronic properties give medicinal chemists and catalyst developers a more predictable starting point than other similar-sized aromatic heterocycles.
Every successful batch reflects the effort put into controlling both raw material quality and process parameters. The main synthesis route we employ starts with the precise selection of 4-fluorobenzaldehyde, combined with carefully handled imidazole. Impurities in either raw input creep into the product as trace aldehydes or ring-opened side-products, so we apply careful pre-reaction purification steps. Any equilibrium between starting materials and products demands close attention to catalytic conditions; just a small temperature drift during the condensation or subsequent cyclization can influence batch purity.
Scaling up from gram-scale lab synthesis to kilogram runs uncovers practical challenges. Heat management becomes one of the most persistent. In our early scale-ups, uncontrolled exotherms repeatedly degraded product, often creating discolored by-products or tarring at the base of reactor vessels. Through iterative cooling improvements – adding baffles, refining agitation, and installing more responsive process controls – we now maintain steady-state conditions that produce consistently high yields.
For final purification, we lean toward recrystallization, usually from ethanol or isopropanol, after liquid-liquid extraction. Our operators have found that slower cooling phases, paired with seeding, generate a purer, more easily filtered crystalline product. These labor-intensive steps are justified by the improved lot-to-lot consistency we now see, and feedback from customers confirms the benefits of taking the extra hours on each batch.
We regularly review our handling protocols to catch new process issues. Static buildup can be a challenge in dry winter months, leading to dusting or loss during transfer. Antistatic protocols, including the use of grounded scoops and humidified air, have greatly reduced these issues in our packing facility. Routine operator training programs, with a focus on safe powder handling and precise weighing, help prevent batch mixing inconsistencies or packing errors.
Each lot gets its certificate of analysis, but what matters to us is going beyond the bare minimum. Our technical team runs every pack lot through a full set of instrumental tests. NMR, HPLC, GC-MS, and elemental analysis are used to screen for organic and inorganic impurities. We believe clarity in analytical reporting helps lab chemists avoid guesswork and wasted time. If there’s ever a question about an order or a test result, we answer directly – the same chemists who run the plant are available for technical follow-up.
Shelf-life and storage stability have also shaped our current production philosophy. Handling feedback from clients who run ambient, no-air controlled storage led us to test more robust moisture-exclusion packaging. The present standard includes double-sealed inner bags, desiccant, and clearly labeled shelf-life expiry supported by real-time batch aging studies. We’ve come to value these practical steps not just for meeting customer demands, but because they cut down our own internal waste by keeping each kilogram usable for months after shipping.
One of the most rewarding parts of manufacturing 1-(4-Fluorophenyl)Imidazole is seeing the breadth of research it supports. We have direct conversations with pharmaceutical teams trying to break new ground in antifungal agents, as well as with academic groups focused on ligand effects in transition metal complexes. Every few months, creative uses emerge from outside these core sectors, including polymer chemistry, advanced materials, and specialty dyes.
Feedback from these labs shapes how we refine our own process. Requests for higher optical purity or more stringent metal content checks have led us to implement new controls and supplier qualification steps. Once, a biotech laboratory needed a 99.5 percent pure batch to avoid interference in a sensitive enzymatic assay. After identifying the trace impurity – a residual by-product from our initial solvent system – we updated the purification route for all subsequent runs, eventually making the improvement a permanent part of our SOP.
In global markets, regulatory questions occasionally arise, such as the eligibility of 1-(4-Fluorophenyl)Imidazole for specific chemical inventory lists. We maintain open records of our quality and regulatory history. Each change in raw material source, process solvent, or packaging is documented and, where necessary, subjected to both in-house and third-party validation. Our direct role as manufacturer means we are accountable for every gram leaving our facility.
International shipping adds another frontier. Some customers report that customs inspections can expose products to temperature spikes or humidity, which threatens product integrity in rare cases. In response, new insulation layers and track-and-trace systems were added, alongside documentation tailored to local import regulations. These lessons came from experience, not textbooks, and they improved outcomes for clients everywhere from major pharmaceutical headquarters to small startups.
Through years of direct supply, the advantages of purchasing 1-(4-Fluorophenyl)Imidazole directly from us show up in technical transparency and batch support. We understand the pressures facing both research scientists and process engineers. Whether a project uses a few grams or hundreds of kilograms, project continuity depends on batches that behave predictably from synthesis through to final formulation.
Beyond standard product support, our technical staff has helped troubleshoot unexpected reaction behavior observed with analog imidazoles. Sometimes a client switches from 1-phenylimidazole to our fluorinated variant only to encounter subtle rate or yield changes. Our chemists explain these shifts by referring to the compound’s altered electron density and reactivity profile, supported by our internal reactivity mapping. This helps clients adapt protocols and avoid costly delays.
Having real-world production experience allows us to recognize market trends and potential pitfalls in scale-up or custom modification requests. We weigh risks honestly and suggest appropriate pilot batches rather than pushing for large-scale commitments when the downstream process remains unproven. This protects both the product’s reputation and helps research teams avoid financial loss.
Quality manufacturing involves more than compliance. Over the past decade, requests for cleaner and greener synthesis pushed us to explore alternative solvents and milder reagents without sacrificing yield. Our process shifted from hazardous chlorinated organics to more benign alcohol-based media. These changes made a measurable difference in both environmental footprint and operator safety.
Customers who encountered specific performance issues have prompted other improvements. For instance, a consistent complaint about static charge during weighing led us to revamp our powder transfer procedures with antistatic tools and climate controls, sharpening both accuracy and operator safety. Another client, running automated synthesis robots, struggled with product clumping. Switching to controlled crystallization resulted in better flowability, quickly solving the bottleneck.
We regularly collect anonymous batch performance reports. Negative feedback isn’t ignored; it’s documented, discussed in weekly meetings, and forms the basis for direct process tweaks. Over time, these incremental changes reduce batch variability and downtime. There is genuine satisfaction in hearing that a long-term client’s synthesis route works better and faster with each new order.
Many innovative future applications for 1-(4-Fluorophenyl)Imidazole are only beginning to emerge. Continued investment in automation, advanced analytics, and supply chain transparency keeps our process aligned with the needs of modern research teams. We build redundancy into our raw material supply and maintain dialogue with both academic and industrial clients, anticipating regulatory and technical changes. The feedback loop between our labs and those of end-users ensures our knowledge base stays practical and our product matches evolving standards.
In our experience, success means more than producing volumes. Responsiveness, technical dialogue, and willingness to refine the process distinguish a manufacturer from a generic supplier. Our clients’ discoveries and successes give meaning to every high-purity kilogram we ship. 1-(4-Fluorophenyl)Imidazole represents more than a chemical compound — it stands as a partnership in scientific progress, grounded in real manufacturing expertise.